KR890700130A - 스테로이달 17α-실릴에테르와 코르티코이드 및 프로게스테론에 관한 방법 - Google Patents

스테로이달 17α-실릴에테르와 코르티코이드 및 프로게스테론에 관한 방법

Info

Publication number
KR890700130A
KR890700130A KR1019880700790A KR880700790A KR890700130A KR 890700130 A KR890700130 A KR 890700130A KR 1019880700790 A KR1019880700790 A KR 1019880700790A KR 880700790 A KR880700790 A KR 880700790A KR 890700130 A KR890700130 A KR 890700130A
Authority
KR
South Korea
Prior art keywords
progesterone
corticosteroids
steroidal
silyl ether
corticoids
Prior art date
Application number
KR1019880700790A
Other languages
English (en)
Other versions
KR960006394B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR890700130A publication Critical patent/KR890700130A/ko
Application granted granted Critical
Publication of KR960006394B1 publication Critical patent/KR960006394B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1019880700790A 1986-11-05 1987-11-02 스테로이달 17α-실릴 에테르 및 코르티코이드와 프로게스테론의 제조 방법 KR960006394B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92763386A 1986-11-05 1986-11-05
US2045787A 1987-03-02 1987-03-02
US927633 1987-03-02
US020457 1987-03-02
PCT/US1987/002818 WO1988003534A1 (en) 1986-11-05 1987-11-02 STEROIDAL 17alpha-SILYL ETHERS AND PROCESS TO CORTICOIDS AND PROGGESTERONES

Publications (2)

Publication Number Publication Date
KR890700130A true KR890700130A (ko) 1989-03-10
KR960006394B1 KR960006394B1 (ko) 1996-05-15

Family

ID=26693463

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880700790A KR960006394B1 (ko) 1986-11-05 1987-11-02 스테로이달 17α-실릴 에테르 및 코르티코이드와 프로게스테론의 제조 방법

Country Status (15)

Country Link
US (1) US4977255A (ko)
EP (2) EP0334875A1 (ko)
JP (2) JP2549721B2 (ko)
KR (1) KR960006394B1 (ko)
AT (1) ATE75484T1 (ko)
AU (1) AU8335587A (ko)
CA (1) CA1317283C (ko)
DE (1) DE3778651D1 (ko)
ES (1) ES2039249T3 (ko)
GR (1) GR3005079T3 (ko)
HK (1) HK69595A (ko)
HU (2) HU892262D0 (ko)
PT (1) PT86083B (ko)
SG (1) SG33647G (ko)
WO (1) WO1988003534A1 (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69132048T2 (de) * 1990-06-11 2000-07-13 Alcon Lab Inc N D Ges D Staate Verwendung von Steroiden zur Inhibierung von Angiogenesis
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
WO1995030684A1 (en) * 1994-05-09 1995-11-16 Pharmacia & Upjohn Company SYNTHESIS OF 17β-CYANO-3-ETHOXY-17α-HYDROXY-6-METHYLANDROSTA-3,5,9(11)-TRIENE
US5929262A (en) * 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
EP2348031B9 (en) 2000-03-17 2016-08-10 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienediones as antiprogestational agents
KR100694079B1 (ko) 2005-01-08 2007-03-12 학교법인 대양학원 유무선 통합 네트워크에서 ｐ２ｐ 서비스를 위한 데이터다운로드 방법 및 그 노드
JP5780521B2 (ja) 2008-05-28 2015-09-16 リベラジェン・バイオファーマ・インコーポレイテッドＲｅｖｅｒａＧｅｎ ＢｉｏＰｈａｒｍａ，Ｉｎｃ． 疾患を治療するための、ＮＦ−κＢの非ホルモン性ステロイド調節因子
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
CN103601786A (zh) * 2013-11-22 2014-02-26 湖南新合新生物医药有限公司 甲基泼尼松龙关键中间体的制备方法
CN103833814A (zh) * 2014-03-06 2014-06-04 浙江仙居君业药业有限公司 17羟基-孕甾-4-烯-3,20-二酮-21-醋酸酯的制备方法
CN103910775A (zh) * 2014-03-31 2014-07-09 仙居县圃瑞药业有限公司 17α-羟基黄体酮的合成方法
CN104311619A (zh) * 2014-07-08 2015-01-28 仙居县圃瑞药业有限公司 一种采用串联法合成黄体酮的方法
CN104311625B (zh) * 2014-11-06 2016-03-23 江西赣亮医药原料有限公司 一种醋酸氟轻松中间体的制备方法
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
CN105801651B (zh) * 2016-04-19 2018-03-06 浙江仙居君业药业有限公司 一种17α‑羟基黄体酮的合成方法
CN109517020B (zh) * 2018-11-22 2020-12-15 湖南原野医药有限公司 Delta-9,11-羟基黄体酮的合成方法
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
CN117257775A (zh) * 2023-11-01 2023-12-22 南京羚诺生物医药技术研究院有限公司 一种子宫内膜异位症用口溶膜制剂及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2082129A5 (ko) * 1970-03-04 1971-12-10 Roussel Uclaf
SE387854B (sv) * 1973-11-21 1976-09-20 O L Lindblad Paverkningsorgan, foretredesvis avsett att anvendas i samband med fordonsekerhetsselar
US4081537A (en) * 1975-10-10 1978-03-28 Schering Aktiengesellschaft Δ15 -Steroids and pharmaceutical compositions thereof
JPS5762296A (en) * 1980-10-01 1982-04-15 Mitsubishi Chem Ind Ltd Preparation of 17alpha-hydroxyprogesterone derivative
JPS5762299A (en) * 1980-10-01 1982-04-15 Mitsubishi Chem Ind Ltd Preparation of 17alpha-cyanosteroid
JPS5762298A (en) * 1980-10-01 1982-04-15 Mitsubishi Chem Ind Ltd Preparation of 17alpha-cyanosteroid
DE3585547D1 (de) * 1984-02-03 1992-04-16 Upjohn Co Steroide mit einer enamid- oder enimidgruppe sowie ihre herstellung.
US4548748A (en) * 1984-02-03 1985-10-22 The Upjohn Company Cyanohydrin process
US4500461A (en) * 1984-02-03 1985-02-19 The Upjohn Company Cyanohydrin process
US4585590A (en) * 1984-02-03 1986-04-29 The Upjohn Company Cyanohydrin process
DE3427486A1 (de) * 1984-07-23 1986-01-30 Schering AG, Berlin und Bergkamen, 1000 Berlin Verfahren zur herstellung von 6(alpha)-methylsteroiden

Also Published As

Publication number Publication date
GR3005079T3 (ko) 1993-05-24
DE3778651D1 (de) 1992-06-04
EP0334875A1 (en) 1989-10-04
ES2039249T3 (es) 1993-09-16
EP0268400A1 (en) 1988-05-25
JP2515967B2 (ja) 1996-07-10
US4977255A (en) 1990-12-11
ATE75484T1 (de) 1992-05-15
CA1317283C (en) 1993-05-04
WO1988003534A1 (en) 1988-05-19
PT86083B (pt) 1990-11-20
HU892262D0 (en) 1992-09-28
JPH02500911A (ja) 1990-03-29
HUT65138A (en) 1994-04-28
SG33647G (en) 1995-09-01
HU209783B (en) 1994-10-28
KR960006394B1 (ko) 1996-05-15
PT86083A (en) 1987-12-01
JP2549721B2 (ja) 1996-10-30
AU8335587A (en) 1988-06-01
EP0268400B1 (en) 1992-04-29
JPH07278183A (ja) 1995-10-24
HK69595A (en) 1995-05-12

Similar Documents

Publication Publication Date Title
KR890700130A (ko) 스테로이달 17α-실릴에테르와 코르티코이드 및 프로게스테론에 관한 방법
DK243085A (da) Fremgangsmaade til fremstilling af 16,17-acetaler af pregnanderivaterog forbindelser fremstillet deraf
JPS54128560A (en) Hydrocortisone derivative
FR1434426A (fr) Procédé pour la préparation d'androst-4-ène-3, 17-dione et d'androsta-1, 4-diène-3, 17-dione à partir de stéroïdes à l'aide de microorganismes
PH12415A (en) 16a,17-cyclopentylidenedioxy-9a-fluoro-11,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate,anti-inflammatory composition and method of use thereof
JPS51134071A (en) Method to eliminate crystal defects of silicon
IL56495A0 (en) Steroids of the pregnane series substituted in the 17-position and the jpreparation and use thereof
JPS52136157A (en) Preparation of steroid 17-esters
JPS52144663A (en) Preparation of pregnane steroid 17alpha-ester 21-halides
PH18164A (en) New 11-hydroxy steroids of the pregnane series substituted in the 17-position and their pharmaceutical compositions
FR2381065A2 (fr) Nouveaux derives halogenes de la serie du 16 a-methyl pregnane
KR920701231A (ko) 6-메틸 19-노르 스테로이드의 제조방법 및 이 화합물을 17α-치환된 19-노르 프레그나디엔으로 전환시키는 방법
ES324499A1 (es) Procedimiento para preparar 6alfa, 9-alfa-difluoresteroides.
JPS5315360A (en) Preparation of pregnane compound 17 alpha-esters
AU542864B2 (en) 18-substituted pregn-4-ene-3,20-diones
ZA79318B (en) New steroids of the pregnane series substituted in the 17-position,and their manufacture and use
ATE71106T1 (de) Verfahren zur herstellung von 1-methyl-androsta- 1,4-dien-3,17-dion und die neuen zwischenprodukte fuer dieses verfahren.
DE2964233D1 (en) Process for the preparation of 19-hydroxy steroids of the androstane and pregnane series
ES8507155A3 (es) Metodo para la obtencion de esteroides de la serie de prednisolona
Jarrett Development Document for the Effluent Limitations and Guidelines for the Ore Mining and Dressing Point Source Category. Volume II
DE3850260T2 (de) Herstellung von 7-beta-Hydroxy-4-pregnen-3,20-dion-Derivaten.
KR790000569B1 (en) Method of producting 62-fluoro-17,21-dehydroxy-16b-methylpregna-4,9(11)-diene-3,20-dione 17,21-diacetate
GR900100749A (el) Μέ?οδος λήψεως νέων αλκοϋλο παραγώγων εις τα 17/21 της 19-NOR προγεστερόνης.
JPS5212179A (en) Preparation of 17alpha ,21-cyclic orthoesters of pregnane steroids
GB1281483A (en) Method for preparing corticosteroids

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20060502

Year of fee payment: 11

LAPS Lapse due to unpaid annual fee